OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral direct activator, OV4071 There were no treatment-related laboratory findings, ...

Many laboratories are racing to improve treatments for nail infections, and one of the newest ideas emerging from European research circles involves a compound better known for its strong sulfur odor.

This Collection is produced with financial support from the Fleming Initiative. Nature Portfolio maintains full independence in all editorial decisions related to the content presented in this ...